[MDGL] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -30.63%
YoY- -204.94%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -70,730 -61,651 -49,023 -19,699 -6,460 -8,347 -3,379 65.97%
Tax 780 0 -1,319 0 -1,166 0 -110 -
NP -71,510 -61,651 -49,023 -19,699 -6,460 -8,347 -3,379 66.27%
Tax Rate - - - - - - - -
Total Cost 71,510 61,651 49,023 19,699 6,460 8,347 3,379 66.27%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -4.18 -3.72 -3.18 -1.28 -0.45 -0.69 -19.18 -22.41%
EPS Diluted -4.18 -3.72 -3.18 -1.28 -0.45 -0.69 -19.18 -22.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.